Indian Pharmaceutical Market Growth in 2024: What You Need to Know

The Indian pharmaceutical market (IPM) experienced a notable 6.1% growth in October 2024, showing its resilience and ability to meet the changing healthcare demands. This growth highlights the sector’s importance to India’s economy and its capacity to adapt to shifting market conditions.

“Key Drivers of Growth”

The growth in October was mainly driven by increased demand for both chronic and acute treatments.

Key categories, such as anti-infectives, gastrointestinal, and cardiovascular drugs, have seen more attention due to rising health awareness and better access to healthcare.
Rural areas have also become a major focus for growth. Thanks to improved distribution networks and government efforts to make healthcare affordable, pharmaceutical products are reaching more people in these areas. “The pharmaceutical sector in India is expanding, addressing the healthcare needs in both urban and rural regions,” said an industry expert.

“Chronic and Acute Therapies Lead the Way”

There is a growing demand for chronic therapies aimed at treating conditions like diabetes, hypertension, and heart disease.

Pharmaceutical companies are focusing more on these treatments to serve a larger patient base.

The demand for acute therapies, such as anti-infectives and respiratory treatments, has also increased. With the winter season approaching, the need for these medications has grown.

“Government Policies and Support”

Government schemes like Ayushman Bharat and the Production Linked Incentive (PLI) scheme have significantly supported the pharmaceutical industry.

These policies aim to make healthcare more affordable and encourage domestic manufacturing, creating an environment that promotes growth.

Advertisement

“Role of Generics and Specialty Drugs”

India continues to lead in the generics market, which has played a major role in the sector’s growth.

Affordable generic drugs have made essential medicines accessible to millions of people. The industry is also shifting its focus toward specialty drugs and biologics, which treat complex medical conditions such as cancer and autoimmune diseases.

Indian pharmaceutical companies are investing more in research and development (R&D) to expand their portfolios of specialty drugs. This will open new revenue opportunities and strengthen India’s position in international markets.

“Challenges and Opportunities”

The pharmaceutical industry faces challenges, including rising costs of raw materials and regulatory scrutiny in export markets.

The global shortage of semiconductors has also affected the production of advanced medical devices, indirectly impacting the supply chain.
However, these challenges present opportunities for growth and innovation. Government programs like the PLI scheme are helping reduce the dependency on imported active pharmaceutical ingredients (APIs), which will support local manufacturing and strengthen the supply chain.

“Outlook for the Future”

Experts expect the Indian pharmaceutical sector to continue growing, driven by innovation, government policies, and increased focus on improving healthcare accessibility.

Chronic therapies, biologics, and expanding export opportunities are expected to drive the industry’s growth in the years ahead.

“The 6.1% growth reflects the sector’s strength and its potential to address global healthcare needs while maintaining its position as the ‘pharmacy of the world,’” said a leading healthcare economist.

Advertisement

Conclusion: The performance of the Indian pharmaceutical market in October 2024 showcases its adaptability and strategic importance. With strong demand for various treatments, increased rural reach, and investments in innovation, the sector is on track for a successful future. As the country’s healthcare system evolves, the pharmaceutical industry will continue to play a key role in economic and social development.

Watch and Subscribe to the YouTube Channel: EBT Entrepreneur Business Times